Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Hosted by SMI Advisor
An in-depth overview of APA’s professional practice guidelines on the use of long-acting injectable antipsychotics (LAIs) in treatment of patients with schizophrenia, including evidence-based findings on advantages of LAIs over oral antipsychotics. REGISTER HERE.
Catherine (Cat) Conroy, M.Ed, Manager of HeadsUp
Neurodevelopment and Psychosis Section, Department of Psychiatry
Perelman School of Medicine, University of Pennsylvania
10th floor, Gates Pavilion, HUP
3400 Spruce Street, Rm. 10054, Philadelphia, PA 19104
headsuppaorg@gmail.com
We are available during standard business hours (Monday-Friday, 9am-5pm) to answer any questions you may have about our organization or to direct you to programs in Pennsylvania that can offer clinical help.
